GSK PLC (OTCPK:GLAXF) Stock News, Headlines & Updates
GSK PLC Stock News from GuruFocus
- 1
- 2
- 3
Jul 24, 2025
GSK (GSK) Gains EU Approval for New Blenrep Therapies
GuruFocus News • 11:57am
GSK Secures EU Nod for Blenrep in Treating Multiple Myeloma | GSK Stock News
GuruFocus News • 11:30am
GSK PLC (GSK) Sponsors 2025 National Senior Games to Raise RSV Awareness | GSK stock news
GuruFocus News • 9:10am
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
Business Wire • 9:00am
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults | GSK Stock News
GuruFocus News • 8:16am
Jul 23, 2025
GSK (GSK) Awaits Extended FDA Review for Blenrep Therapy
GuruFocus News • 12:59pm
FDA Extends Review for GSK's Blenrep Combinations for Multiple Myeloma | GSK Stock News
GuruFocus News • 11:16am
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc -- GSK
Marketwired • 9:00am
Jul 22, 2025
GSK Stock Experiences Significant Bearish Options Activity | GSK Stock News
GuruFocus News • 10:46am
Jul 21, 2025
GSK (GSK) Price Target Reduced by Morgan Stanley | GSK Stock News
GuruFocus News • 11:46am
Jul 18, 2025
GSK (GSK) Price Target Slashed by Morgan Stanley Amid Sales Concerns | GSK Stock News
GuruFocus News • 1:15pm
Jul 17, 2025
GSK Faces FDA Advisory Setback on Blenrep Dosage for Multiple Myeloma | GSK Stock News
GuruFocus News • 4:30pm
GSK Stock Dips as FDA Panel Rejects Blenrep Combination
GuruFocus News • 12:56pm
GSK PLC (GSK) Stock Price Down 4.49% on Jul 17
GuruFocus News • 12:04pm
GSK Secures FDA Approval for Easier-to-Use Shingrix Prefilled Syringe
GuruFocus News • 8:56am
GSK PLC (GSK) Announces FDA Approval for New SHINGRIX Prefilled Syringe | GSK stock news
GuruFocus News • 8:13am
US FDA Approves GSK's SHINGRIX in a Prefilled Syringe Presentation
Business Wire • 7:00am
GSK's New Prefilled Shingrix Syringe Gains FDA Approval | GSK Stock News
GuruFocus News • 6:30am
US FDA Approves GSK's SHINGRIX in a Prefilled Syringe Presentation | GSK Stock News
GuruFocus News • 6:19am
FDA Greenlights Simplified SHINGRIX Syringe from GSK for Shingles Prevention | GSK Stock News
GuruFocus News • 5:49am
Jul 15, 2025
GSK Shares Decline Following FDA Review of Blenrep | GSK Stock News
GuruFocus News • 10:16am
Jul 14, 2025
GSK (GSK) Expands Licensing Agreement for Generic HIV Drug Production
GuruFocus News • 11:57am
GSK Awaits FDA Decision on Expanded Use of RSV Vaccine Arexvy
GuruFocus News • 10:55am
GSK Expands HIV Treatment Access with Updated Licensing Agreement | GSK Stock News
GuruFocus News • 9:17am
GSK's ViiV Healthcare Reports Positive Outcomes in HIV Treatment Study | GSK Stock News
GuruFocus News • 9:17am
GSK Seeks FDA Approval to Expand RSV Vaccine Use for Younger Adults | GSK Stock News
GuruFocus News • 5:46am
Jul 11, 2025
GSK PLC (GSK) Shares Gap Down to $38.3765 on Jul 11
GuruFocus News • 12:03pm
Delaware Supreme Court Sides with GSK in Zantac Cancer Case
GuruFocus News • 6:56am
Jul 10, 2025
Delaware Supreme Court Overturns Ruling on GSK's Zantac Case | GSK Stock News
GuruFocus News • 2:45pm
Delaware Supreme Court Dismisses Zantac Cancer Claims Linked to GSK | GSK Stock News
GuruFocus News • 2:30pm
GSK begins shipping influenza vaccine doses for the 2025-26 flu season
Business Wire • 9:00am
GSK Begins Distribution of Trivalent Flu Vaccines for 2025-26 Season | GSK Stock News
GuruFocus News • 8:46am
GSK begins shipping influenza vaccine doses for the 2025-26 flu season | GSK Stock News
GuruFocus News • 8:31am
Jul 09, 2025
GSK (GSK) Sees Surge in Bullish Options Activity | GSK Stock News
GuruFocus News • 11:45am
Jul 07, 2025
GSK Faces Risks with RSV Vaccine (GSK)
GuruFocus News • 11:58am
Jun 27, 2025
GSK Under Investigation for Discontinuing Flovent HFA Inhaler
GuruFocus News • 9:57am
Jun 24, 2025
FDA Approves GSK's Benlysta Autoinjector for Lupus Treatment
GuruFocus News • 9:56am
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
Business Wire • 9:00am
FDA Approves GSK's New Benlysta Autoinjector for Pediatric Lupus Nephritis | GSK Stock News
GuruFocus News • 8:32am
FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis | GSK Stock News
GuruFocus News • 8:25am
- 1
- 2
- 3
Show
Entries
Headlines
Total 0- 1
No recent news